SCHEMBL19076325

SCHEMBL19076325

c1ccc(-c2c3ccccc3c(-c3cccc(-c4cc5ccccc5c5c4oc4c5ccc5oc6ccccc6c54)c3)c3ccccc23)cc1

nearest known ligand 0.36

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PLA2G2A P14555 4/20 0.36
PLA2G4A P47712 4/20 0.36
PLA2G10 O15496 1/20 0.36
TDP1 Q9NUW8 1/20 0.35
L3MBTL1 Q9Y468 1/20 0.35
ABCG2 Q9UNQ0 3/20 0.35
CYP1A1 P04798 2/20 0.35
CYP1A2 P05177 2/20 0.35
FYN P06241 1/20 0.35
MAPK3 P27361 1/20 0.35
AHR P35869 1/20 0.35
PAX8 Q06710 1/20 0.35
ALOX5 P09917 2/20 0.34
GPR84 Q9NQS5 3/20 0.34
RAB9A P51151 3/20 0.33
KDM4E B2RXH2 2/20 0.33
CYP1B1 Q16678 2/20 0.33
CA1 P00915 2/20 0.33
CA2 P00918 2/20 0.33
GABRP O00591 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL19076419 0.93 TDP1 (0.35) PLA2G2APLA2G4APLA2G10TDP1L3MBTL1
SCHEMBL19076396 0.93 GPR84 (0.40) PLA2G2APLA2G4APLA2G10TDP1L3MBTL1
SCHEMBL9950744 0.90 ALOX5 (0.39) TDP1L3MBTL1ABCG2CYP1A1CYP1A2
SCHEMBL10130465 0.88 ALOX5 (0.40) PLA2G2APLA2G4APLA2G10TDP1L3MBTL1
SCHEMBL10130456 0.86 PLA2G2A (0.38) PLA2G2APLA2G4APLA2G10TDP1L3MBTL1
SCHEMBL18996163 0.86 PLA2G2A (0.38) PLA2G2APLA2G4APLA2G10TDP1L3MBTL1
SCHEMBL10130442 0.85 PLA2G2A (0.40) PLA2G2APLA2G4APLA2G10TDP1L3MBTL1
SCHEMBL9949773 0.85 PLA2G2A (0.40) PLA2G2APLA2G4APLA2G10TDP1L3MBTL1
SCHEMBL29406326 0.85 PLA2G2A (0.40) PLA2G2APLA2G4APLA2G10TDP1L3MBTL1
SCHEMBL19079924 0.85 CYP1A1 (0.44) ABCG2CYP1A1CYP1A2FYNMAPK3

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20170194573-A1 CONDENSED CYCLIC COMPOUND AND AN ORGANIC LIGHT-EMITTING DEVICE INCLUDING THE SAME SAMSUNG DISPLAY CO., LTD. (KR) 2017-07-06 US disclosed
US-20170194573-A1 CONDENSED CYCLIC COMPOUND AND AN ORGANIC LIGHT-EMITTING DEVICE INCLUDING THE SAME SAMSUNG DISPLAY CO., LTD. (KR) 2017-07-06 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20170194573-A1 CONDENSED CYCLIC COMPOUND AND AN ORGANIC LIGHT-EMITTING DEVICE INCLUDING THE SAME CRY1, CRY2, CCNT1 PLA2G2A 4330/4885PLA2G4A 4338/4885PLA2G10 4054/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.